$1.010
+0.010 (+1.00%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de INO por análisis de gráficos similares
Alphio's INO stock price prediction model matches the current Inovio Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.80 (+1.08%). The 1-week path is $0.85 (+6.59%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Inovio Pharmaceuticals Inc?
Inovio Pharmaceuticals Inc is currently not a strong buy due to its recent performance and financial metrics. The stock is priced at $0.9901, down 41.41% year-to-date and 59.91% over the past year. The RSI is at 32.396, indicating it is approaching oversold territory, but the forward P/E ratio of 16.5837 suggests potential future earnings growth. The main risk is the recent public offering that caused a 20% drop in after-hours trading, reflecting market concerns about dilution.
INO cerró en $1.01 el Tuesday, tras subir +1.00%
Inovio Pharmaceuticals Inc (INO) last closed at $0.7953, losing -21.26%. These facts feed the 1-day and 1-week INO price prediction above.
Consenso de analistas
Inovio Pharmaceuticals Inc (INO): 6 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Inovio Pharmaceuticals Inc (INO) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de INO, ordenadas por similitud.
Análisis de estacionalidad de INO
Historically the probability of a positive October return for INO is 37.70%. February offers the highest probability of a positive month at 68.97%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.